Tag Archive | "pharma partners"

Rockwell forms a biotech partnership with Baxter for $45 million

Tags: , , , ,


Baxter International gave kidney drug developer Rockwell Medical a big boost in the form of $45 million in graduated payments in a biotech partnership. Read the full story

Baxter and Merrimack ink a pharma licensing deal for developing cancer drug

Tags: , , ,


Baxter International had entered into an exclusive pharma licensing and collaboration agreement with Merrimack Pharmaceuticals to develop and commercialize lead cancer drug MM-398. Read the full story

Boehringer Ingelheim and CureVac announce a pharma licensing deal

Tags: , ,


Boehringer Ingelheim and CureVac have entered an exclusive global pharma licensing deal and development partnership to focus on CureVac’s CV9202, netting CureVac $556 million ($45 million upfront). Read the full story

Myokardia forms pharma partnership with Sanofi for Cardiomyopathy

Tags: , , , , ,


Sanofi forms pharma partnership with MyoKardia on a $200 million initiative to develop new therapies to help treat deadly genetic heart muscle disease. Read the full story

Gilead Sciences to sign a generic pharma licensing deal for Hep C drug

Tags: , , , ,


Gilead Sciences is close to a pharma licensing deal with generic drugmakers to bring low-cost versions of its $84,000 hepatitis C drug Sovaldi to about 80 developing countries including India, Indonesia, and Pakistan. Read the full story

Start-up Calico becomes AbbVie’s pharma partner

Tags: , ,


AbbVie and Calico, pharma partner, announced a collaboration agreement, which will include an R&D facility in the San Francisco Bay area. Read the full story

Viacyte and Janssen sign a pharma deal

Tags: , ,


ViaCyte has entered into a pharma deal with Janssen Research & Development for VC-01. Read the full story

Novartis and TB Alliance sign a pharma licensing agreement

Tags: , , ,


Novartis has signed an exclusive worldwide pharma licensing agreement with the Global Alliance for TB Drug Development for compounds to fight tuberculosis that have been discovered at the Novartis Institutes for Tropical Diseases. Read the full story

23andMe and Pfizer become pharma partners for IBD treatment

Tags: , , ,


23andMe and Pfizer are pharma partners for initiating research on genetic factors of IBD. Read the full story

Emergent Biosolutions signs biotech deal with CDC

Tags: , ,


Emergent BioSolutions announced a biotech deal with Centers for Disease Control and Prevention has exercised options under contract 200-2012-52242 for the supply of Vaccinia Immune Globulin Intravenous into the U.S. Strategic National Stockpile. Read the full story